中国科学院机构知识库网格系统: 检索

浏览/检索结果: 共4条，第1-4条

帮助

条数/页：排序方式：
	Design, Synthesis, and Biological Evaluation of Orally Bioavailable CHK1 Inhibitors Active against Acute Myeloid Leukemia 期刊论文 OAI收割 CHEMMEDCHEM, 2021, 页码: 12 作者: Jin, Tingting; Wang, Peipei; Long, Xiubing; Jiang, Kailong; Song, Pinrao \| 收藏 \| 浏览/下载：137/0 \| 提交时间：2021/05/24 CHK1 inhibitor diaminopyrimidine DNA damage response oral bioavailability
	Discovery of (R)-5-((5-(1-methyl-1H-pyrazol-4-yl)-4-(methylamino) pyrimidin-2-yl)amino)-3-(piperidin-3-yloxy)picolinonitrile, a novel CHK1 inhibitor for hematologic malignancies 期刊论文 OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 卷号: 173, 页码: 44-62 作者: Tong, Lexian; Song, Pinrao; Jiang, Kailong; Xu, Lei; Jin, Tingting \| 收藏 \| 浏览/下载：31/0 \| 提交时间：2020/07/01 CHK1 kinase inhibitor Selectivity Monotherapy Hematologic malignancies
	Design, synthesis and biological evaluation of thienopyridinones as Chk1 inhibitors 期刊论文 OAI收割 BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 卷号: 22, 期号: 17, 页码: 4882-4892 作者: Song, Pinrao; Peng, Peng; Han, Mengmeng; Cao, Xianchao; Ma, Xiaodong \| 收藏 \| 浏览/下载：32/0 \| 提交时间：2019/01/08 Chk1 inhibitor Thienopyridinones Antitumor Cell synergy
	Proteasome-dependent degradation of Chk1 kinase induced by the topoisomerase II inhibitor R16 contributes to its anticancer activity 期刊论文 OAI收割 CANCER BIOLOGY & THERAPY, 2008, 卷号: 7, 期号: 11, 页码: 1726-1731 作者: Feng, Jian-Ming; Zhu, Hong; Zhang, Xiao-Wei; Ding, Jian; Miao, Ze-Hong \| 收藏 \| 浏览/下载：27/0 \| 提交时间：2019/01/08 topoisomerase II inhibitor naphthalimide R16 colon carcinoma Chk1 proteasome anticancer activity